Estimated prevalence of implanted electrophysiologic devices in patients with heart failure
Roger M. Mills(Janssen (Belgium)), Zhong Yuan(Janssen (United States)), Robert Cody(University of Michigan), Vivienne J. Zhu(Janssen (United States))
Cited by 1
Related Papers
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|New England Journal of Medicine|1999|9.1k
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|Survey of Anesthesiology|2000|2.9k
Reflex Increase in Coronary Vascular Resistance in Patients with Ischemic Heart Disease
|New England Journal of Medicine|1976|480
Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure
|Journal of the American College of Cardiology|1999|323
Nitroprusside in Critically Ill Patients with Left Ventricular Dysfunction and Aortic Stenosis
|New England Journal of Medicine|2003|278